Navigation Links
Stroke victims have new hope with activated protein C

A new study by researchers from the University of Rochester, New York suggests that the activated protein C (APC), a protein with anti-inflammatory and anti-coagulant properties,which until now is being used to treat septic infections, may also help reduce the damage caused by stroke. Researchers who conducted the study on mice found that APC could protect brain cells from the secondary damage associated with ischemic stroke by preventing apoptosis, a form of programmed cell death. The study has shown// that APC reduced apoptosis by 65 per cent and neurological deficits by 91 per cent when given to mice following a stroke. Currently, only tissue plasminogen activator is useful for the 80 per cent of strokes that involve a blood clot, but can damage cells if given after the first few hours.

Further analysis by this team of researchers has shown that APC blocks p53, a molecule that drives cells towards apoptosis following stroke. APC works through two cellular receptors, called endothelial protein C receptor and protease-activated receptor 1, to reduce the level of p53 in damaged cells by 75 per cent. APC also increases anti-apoptotic signals that instruct cells to survive. Researchers concluded that the compound which is working in a completely unexpected way could spur further research to help develop treatments that reduce the lifelong disability often associated with stroke.


'"/>




Page: 1

Related medicine news :

1. Amphetamines Help Recovery of Stroke Patients
2. Cough Syrup Ingredient Linked to Stroke
3. Estrogen Does Not Prevent Recurrent Strokes
4. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
5. Triglycerides Linked To Stroke Risk
6. Strokes increased during squatting
7. Drug Combinations May Boost Stroke Risk
8. Stroke and Dementia - a ghastly association
9. Stroke risk might be linked to antibody
10. Stroke Risk and Fish :A factual interconnection
11. Fewer teeth & Increased Ischemic Stroke risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... For the second year, ... student to educate the public on the impact of concussions. Brooke Mills, student ... National Concussion Awareness Day. , Brooke is working diligently is to raise awareness ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... partnerships through affiliations and de novo development, today announced Cumberland Skin Surgery ... Cumberland Skin Surgery and Dermatology, with offices in both Hermitage and Lebanon, Tennessee, ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern Telehealth ... grant totaling $975,000, renewing its funding from the Health Resources and Services Administration ... funding marks, the fourth time the HRSA administration has renewed its financial support ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment of clubfoot, ... all 29 Indian states—bringing the country one step closer to eliminating clubfoot as a ... organization is on track to enroll 10,000 children in the clubfoot treatment program in ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Melbourne’s reign ... by the prestigious Economist Intelligence Unit’s (EIU) annual Liveability Index. , The Index surveys ... Since the index began in 2006, Melbourne has consistently come in the top three ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Mich. , Aug. 15, 2017 Diplomat ... naloxone to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher ... approved by the Food and Drug Administration, is intended ... extreme drowsiness, slowed breathing, and loss of consciousness. The ...
(Date:8/15/2017)... WILMINGTON, N.C. , Aug. 15, 2017 ... Wilmington, NC , today announced that the company ... at the University of North Carolina at Chapel Hill ... AccuKit-HIV is designed to characterize and quantify HIV reservoir ... and after pharmacological intervention. The HIV Cure Center is ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
Breaking Medicine Technology: